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ABSTRACT 
Atopic dermatitis (AD) is a chronic relapsing, pruritic, inflammatory skin disease 
in children associated with personal or family history of other atopic disease like 
asthma, allergic rhinitis. Clinically characterized by itching, dryness, erythema, 
vesiculation, exudation and lichenification etc. The present treatment for AD in 
modern science is steroids or calcinueurin inhibitors. But repeated course of 
steroids can cause immuno suppression and growth retardation. The drugs in 
Siddha system of medicine is well known for their effectiveness and less toxicity. 
One such medicine is Uthamani Chooranam (UC) indicated for AD. The activity of 
UC was studied by using histamine induced paw oedema in rats by 
phenylbutazone. Exposure of rats hind paw to histamine resulted in marked 
increase of paw tissue weight and skin thickness. After oral administration of UC 
at various dose levels of 200mg/kg and 400mg/ kg reduce the paw volume when 
compared to control group. The present studies shown the Siddha drug UC is 
significantly reduce the paw oedema and this study supports the anti-histamine 
effect of UC. 
KEYWORDS: Atopic dermatitis (AD), Uthamani chooranam (UC), Anti- Histaminic 
activity, Phenylbutazone. 
INTRODUCTION 
Atopic dermatitis (AD) often called 
eczema is a chronic, highly pruritic 
inflammatory skin disease, and is one of the 
most common skin disorder in children. 
Clinically characterized by dry, itchy, scaly 
skin, cracks, rashes on cheeks, arm, legs, 
weeping, crusting, and lichenification [1]. The 
prevalence of AD has increased over the past 
30 years. It is currently estimated that 10- 
20% of children and 1-3% of adults in 
developed countries are affected by the 
disorder. AD often starts in early infancy 
approximately 45% of all cases begin within 
the first 6 months of life, 60% during the 
first year, and 85% before 5 years of age. Up 
to 70% of these children outgrow the 
disorder before adolescence. Children with 
AD are at high risk of developing asthma and 
allergic rhinitis. The pathogenesis of AD is 
multi factorial, the following factors like 
genetics, skin barrier dysfunction, impaired 
immune response, environment, are thought 
to play varying roles in AD [2]. 
 The potential AD triggers are 
classified into three factors, they are 
associated with direct contact are toiletries 
containing alcohol, soaps, abrasive clothing. 
Associated with emotional stressors, 
infection, overheating/sweating, 
psychological stress. Associated with food 
are allergens found in cow's milk, eggs, 
peanuts, tree nuts, soy, wheat, fish [3].  
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 The clinical features of AD correlates 
with the symptoms of Balakarappan 
described in the Siddha text Balavagadam. In 
Siddha literature Bala karappan is one of the 
eighteen types of "Karappan noi" that occurs 
in children. This skin disease was described 
by various Siddhars in detail about the 
general etiology, signs & symptoms and 
prognosis on the basis of three Thosha and 
Envagai thervugal, one of the causes of 
Karappan was consumption of non- 
vegetarian foods, intake of maize, pearl 
millet, foxtail millet, little millet and certain 
tuberous root [4]. 
 AD can be usually controlled with 
corticosteroids, topical immuno modulators, 
moisturizers, topical calcineurin inhibitors, 
anti-histamines, and oral cyclosporines. It 
can produce adverse effects like skin 
thinning, possible hypothalamo pituitary-
adrenal axis suppression, growth retardation 
in children and malignancies are caused due 
to prolonged use of immuno modulators [5]. 
Because of their side effects a newer 
effective drug with lesser side effects is 
necessary. In Siddha system of medicine 
many herbal drugs are non toxic, low cast, 
easily available, with their effectiveness in 
the treatment of AD mentioned in various 
Siddha literature. One of such medicine was 
Uthamani chooranam mentioned in the 
siddha text Koshayi Anuboga Vaidhya 
Bremma Ragasiyam [6]. 
 The drug Uthamani chooranam is 
containing whole plant of Pergularia daemia 
which possesses alkaloids, glycosides, 
steroids, flavanoids, cardenolides, saponin, 
tannin, phenolic compounds, terpenoids [7]. 
Hence in the present study an effort has 
been made to evaluate the Anti histaminic 
activity of Uthamani Chooranam in 
Histamine induced Hind paw oedema in rats. 
MATERIALS AND METHODS 
 The Uthamani chooranam contains 
the whole plant of Pergularia daemia is 
known as "Veliparuthi" belongs to the family 
Asclepediaceae. The plant material was 
collected from the fertile area of Arakkonam, 
Vellore district, Tamilnadu, India. The plant 
was identified and authenticated by the 
pharmacology experts of post graduate 
department of Gunapadam. Govt. Siddha 
Medical College, Arumbakkam, Chennai. 
Plants of Pergularia daemia were air dried 
under shade, powdered with a mechanical 
grinder, filtered in fine cloth then the fine 
powder made into Chooranam. This powder 
was sieved through a clean white cloth and 
further purified by Pittaviyal method (steam 
boiling with milk) based on Siddha classical 
literature[8].  
  The Chooranam was moistened with 
cow’s milk and made into a solid form. Then 
it is kept in a clean cloth which is tied to the 
mouth of a mud vessel containing equal 
amount of cow’s milk and water. Then it is 
finally covered over with a top vessel and 
their junction is covered with a cloth, so that 
vapor does not escape while boiling. After 
boiling and complete evaporation of liquid, 
the solid mixture is taken and dried in 
sunlight and grinded finally and stored in an 
air tight container kept at room temperature. 
This Chooranam was labeled as UC and used 
for the present study.  
 
Figure 1: Whole plant of Pergularia daemia 
 
Figure 2: Final drug -Uthamani chooranam 
Preparation of stock solution 
 The suspension of Siddha drug UC in 
2% (W/V) CMC (Chemistry manufacturing 
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control) was prepared for oral 
administration by gastric intubation in rats.  
Animals 
 Swiss albino rats of female sex 
weighing about 230-250 gm were obtained 
from the animal house of King Institute of 
Preventive Medicine, Guindy, Chennai. The 
animals were acclimated to standard 
laboratory condition (temperature – 24 to 
28oC and humidity 60- 70%) and maintained 
on 12 hr light/ dark cycle. The animals were 
housed in polypropylene cages at C.L. Baid 
Metha College of Pharmacology, 
Thoraipakkam, Chennai, and fed with 
standard rodent pellet obtained and water 
ad libitum. The present study was approved 
by the institutional animal ethical committee 
(IAEC) with the approval number: 
IAEC/XXXIX/12/CLBMCP/2013/ dated 
29.6.2013. 
Acute toxicity studies 
 The acute oral toxicity study was 
carried out as per OECD guidelines 423. One 
tenth of the median lethal dose was taken as 
an effective dose[9]. 
Evaluation of the Anti histaminic activity 
Histamine induced paw oedema in rats 
Exposure of rat’s hind paw to 
histamine resulted in a marked increase of 
paw tissue weight and skin thickness. Single 
intra plantar injection of 0.1                                                            
ml of 1% of histamine will produce 
significant increase in paw volume. The 
change in hind paw volume was measured 
using plethysmometer and expressed as 
mean paw volume of left hind paw of the 
rats. After the induction of paw oedema, the 
increase in paw volume was calculated at a 
fixed interval of 0, 60, 120, 240 and 180 
mints. The change in paw volume was 
measured as the difference between the 
final and initial paw volume. Standard 
Phenylbutazone (100 mg/kg) were used as 
standard drug and administered as CMC 
suspension by oral route. 
Animal Grouping 
Group I- Negative control - single intra 
plantar injection of 0.1 ml of 1 % of 
histamine. 
Group II- Histamine+ Low dose of test drug 
(200 mg/kg) p.o. 
Group III- Histamine+ High dose of test 
drug(400 mg/kg) p.o 
Group IV- Histamine + Standard 
Phenylbutazone (100 mg/kg) p.o 
Table1: Estimation of Paw volume at different time intervals 
Paw volume at different time intervals (ml) (mean ±SEM) 
Groups and Drugs 0 min 60 min 120 min 180 min 240 min 
Histamine 0.266± 
0.05 
0.761± 
0.02 
0.882± 
0.01 
0.954± 
0.05 
1.181±0.08 
Histamine + Low 
dose of Test Drug  
0.27± 
0.01 
0.561± 
0.03 
0.746± 
0.08 
0.891± 
0.09 
1.033± 
0.02 
Histamine + High 
dose of Test Drug  
0.252± 
0.04 
0.488± 
0.02 
0.624± 
0.01 
0.786± 
0.03 
0.824± 
0.04 
Histamine + 
Phenylbutazone 
0.251± 
0.05 
0.287± 
0.06 
0.348± 
0.01 
0.372± 
0.01 
0.41± 
0.02 
Mean changes in paw volume using 
mercury Plethysmometer in rats n=6, values 
are expressed as mean ± SEM.* P < 0.05, 
significantly different from negative control 
(histamine only). 
STATISTICAL ANALYSIS 
 The statistical analysis was carried by 
one way ANOVA (GRAPH PAD PRISM 5 
computer program). Results are expressed 
as mean ± SEM. A statistical comparison was 
carried out using the Dunnets 't' multiple 
comparison test for comparing control and 
treatment group. 
RESULTS AND DISCUSSION 
 Observation of results predicts that 
histamine induced group shows increased 
displacement value ranges from 0.26 to 1.18. 
Treatment with test drug at the dose of 200 
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mg/kg shown displacement of value ranges 
from 0.27 to 1.03. Treatment with the dose 
of 400mg/kg shown displacement of value 
ranges from 0.25 to 0.82. Treatment with 
standard drug at the dose of 100mg/kg 
shown displacement of value ranges from 
0.25 to 0.41. From the observation it was 
conclude that test drug at both the dose level 
significantly [p< 0.05] reduced the paw 
oedema induced by Histamine at plantar 
region. 
 Histamine is one of the inflammogens 
that contributes to acute inflammation and 
increase of vascular permeability. It is 
reported earlier that the drug 
phenylbutazone has the capacity to reduce 
the histamine concentration by decreasing 
the vascular permeability [10]. The present 
study document the ability of Uthamani 
chooranam (whole plant of Pergularia 
daemia) to suppress the histamine induced 
inflammation in rats compared with control 
group. The results show that Uthamani 
chooranam was able to suppress histamine 
induced paw oedema in rats. 
CONCLUSION 
 The results of the present study 
demonstrate that the Uthamani chooranam 
has significant anti-histaminic activity by the 
suppression of increased vascular 
permeability, reflected in the decreased paw 
volume in rats. It has been concluded that 
the potent Anti-histaminic activity of 
Uthamani chooranam in rats and this results 
contribute towards the validation of the 
traditional use Uthamani chooranam in the 
treatment of Atopic Dermatitis. 
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